A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients-Reference-Cited by-同舟云学术

A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients

Published:2016-05-24 Issue:7 Volume:36 Page:945-953
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Pamuk Ömer Nuri,Kalyoncu Umut,Aksu Kenan,Omma Ahmet,Pehlivan Yavuz,Çağatay Yonca,Küçükşahin Orhan,Dönmez Salim,Çetin Gözde Yıldırım,Mercan Rıdvan,Bayındır Özün,Çefle Ayşe,Yıldız Fatih,Balkarlı Ayşe,Kılıç Levent,Çakır Necati,Kısacık Bünyamin,Öksüz Mustafa Ferhat,Çobankara Veli,Onat Ahmet Mesut,Sayarlıoğlu Mehmet,Öztürk Mehmet Akif,Pamuk Gülsüm Emel,Akkoç Nurullah

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-016-3500-9.pdf

Reference27 articles.

1. Younes M, Korbaa W, Moussa A, Zrour S, Bejia I, Touzi M et al (2009) Prevalence of subclinical amyloidosis in Tunisian patients with rheumatoid arthritis. Joint Bone Spine 76:254–259

2. Singh G, Kumari N, Aggarwal A, Krishnani N, Misra R (2007) Prevalence of subclinical amyloidosis in ankylosing spondylitis. J Rheumatol 34:371–373

3. Westermark GT, Fändrich M, Westermark P (2015) AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol 10:321–344

4. Real de Asúa D, Costa R, Galván JM, Filigheddu MT, Trujillo D, Cadinanos J (2014) Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol 6:369–377

5. Pamuk ON, Donmez S, Pamuk GE, Puyan FO, Keystone EC (2013) Turkish experience in rheumatoid arthritis patients with clinical apparent amyloid deposition. Amyloid 20:245–250

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review;Kidney International;2023-03

2. Treating Rheumatoid Arthritis by Genetically Engineered Biological Drugs: A Case Study.;International Journal of Life Science and Pharma Research;2022-07-17

3. Frequency of Renal Function Parameter Abnormalities in Patients with Psoriatic Arthritis and Rheumatoid Arthritis: Real-World Evidence from Clinical Practice;Journal of Clinical Medicine;2022-02-16

4. Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy;Medicine;2021-08-13

5. Connection of COX‐2 variants to ankylosing spondylitis susceptibility;Journal of Cellular Physiology;2021-02-09